MEDICINOVA, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
MEDICINOVA, INC. (MNOV) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of 0.60% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2025-02-19
- MEDICINOVA, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2024 was 0.60%.
- MEDICINOVA, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2023 was -3.80%.
- MEDICINOVA, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2022 was -2.60%.
- MEDICINOVA, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2021 was -2.80%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | 0.60% 10-K · filed 2025-02-19 | |
| 2023-12-31 | -3.80% 10-K · filed 2025-02-19 | |
| 2022-12-31 | -2.60% 10-K · filed 2024-02-15 | |
| 2021-12-31 | -2.80% 10-K/A · filed 2023-03-28 | |
| 2020-12-31 | -2.10% 10-K · filed 2022-02-16 | |
| 2019-12-31 | -2.00% 10-K · filed 2021-02-19 | |
| 2018-12-31 | -1.50% 10-K · filed 2020-02-13 | |
| 2017-12-31 | -1.10% 10-K · filed 2019-02-13 | 1.10% 10-K · filed 2018-02-13 |
| 2016-12-31 | -0.90% 10-K · filed 2019-02-13 | 0.90% 10-K · filed 2017-02-14 |
| 2015-12-31 | 1.40% 10-K · filed 2018-02-13 | |
| 2014-12-31 | 1.20% 10-K · filed 2017-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |